Brief: Fractyl Health Completes Randomization In Remain-1 Pivotal Cohort Of Revita®
Feb 26 (Reuters) - Fractyl Health Inc GUTS.O: FRACTYL HEALTH COMPLETES RANDOMIZATION IN REMAIN-1 PIVOTAL COHORT OF REVITA® FOR POST-GLP-1 WEIGHT MAINTENANCE FRACTYL HEALTH INC - TOPLINE DATA EXPECTED EARLY Q4 2026, FDA SUBMISSION LATE Q4 2026 FRACTYL HEALTH INC - REITERATES CASH RUNWAY GUIDANCE INTO EARLY 2027 Source text: ID:nGNX4pRyJX Further company coverage: GUTS.O ((Reuters.Briefs@thomsonreuters.com;))